Matthias Merkel, M.D., Ph.D., discusses how OHSU Mission Control worked with GE Healthcare, the Oregon Healthy Authority and health systems statewide to share bed and ventilator data as the COVID-19 pandemic gained a foothold in the U.S.

Researchers at OHSU and the University of Oregon collaborate to address stress and burnout among special education teachers.

The latest installment of a series of interviews features comment from Dawn Nolt, M.D., about the potential of a new vaccine becoming widely available by next spring.

A study conducted by Atul Deodhar, M.D., finds that Ixekizumab improves symptoms related to radiographic axial spondyloarthritis.

In a story about new research results of neurosurgery patients treated for Parkinson’s disease, Matt Brodsky, M.D., says: “These data are very encouraging as they further reinforce that directional deep brain stimulation therapy may benefit a wide variety of patients living with Parkinson disease.”

A post about death with dignity quotes David Pollack, M.D., stating that a “growing body of evidence clearly distinguishes the characteristics of persons who (die by suicide) resulting from mental illness from those of terminally ill persons who requests medical aid in dying.”

A column, authored by Joel Nigg, Ph.D., highlights how COVID-19 has further impacted mental health, suicide risk and ADHD.

Gordon Mills, M.D., Ph.D., will present as a Key Opinion Leader on advanced solid tumors in a virtual meeting held by Zentalis Pharmaceuticals.

Gopal Allada, M.D., discusses the health effects of wildfire smoke and recommends staying indoors, among other guidance.

An article on the importance of foundations in health care mentions the OHSU Knight Cancer Institute supported staffing and outreach needs of a new mammogram program to encourage mammogram screening in the Latinx population.